Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency

Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-acting effects. However, its blood concentration has been reported to increase in combination with clopidogrel, an antiplatelet dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Kana, Fujii, Kohei, Yamaguchi, Hiroki, Miyoshi, Yumika, Uehara, Yuhei, Nagata, Shimpei, Obata, Yoshinari, Kosugi, Motohiro, Hazama, Yoji, Yasuda, Tetsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024957/
https://www.ncbi.nlm.nih.gov/pubmed/33716254
http://dx.doi.org/10.2169/internalmedicine.5578-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024957/
https://www.ncbi.nlm.nih.gov/pubmed/33716254
http://dx.doi.org/10.2169/internalmedicine.5578-20

Ejemplares similares